Announcement

Collapse
No announcement yet.

Research Articles Abstract - 2012 Issues Archive

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • #16
    Research Articles Abstracts?April 21 2012 Issue

    [Source: AMEDEO, homepage: (LINK).]

    Research Articles Abstracts?April 21 2012 Issue



    Abstracts List
    • Tan AC, Eriksson EM, Kedzierska K, Deliyannis G, et al.
      • Polyfunctional CD8(+) T cells are associated with the vaccination-induced control of a novel recombinant influenza virus expressing an HCV epitope.
    • Katz LM.
      • How can the blood transfusion medicine community contribute to public health in tough economic times?
    • Do LA, van Doorn HR, Bryant JE, Nghiem MN, et al.
      • A sensitive real-time PCR for detection and subgrouping of human respiratory syncytial virus.
    • Kikuchi T, Iwatsuki-Horimoto K, Adachi E, Koga M, et al.
      • Improved neutralizing antibody response in the second season after a single dose of pandemic (H1N1) 2009 influenza vaccine in HIV-1-positive adults.
    -
    ------

    Comment


    • #17
      Research Articles Abstracts?April 28 2012 Issue

      [Source: AMEDEO, homepage: (LINK).]

      Research Articles Abstracts?April 28 2012 Issue



      Abstracts List
      1. Zu M, Yang F, Zhou W, Liu A, et al.
        • In vitro anti-influenza virus and anti-inflammatory activities of theaflavin derivatives.
      2. Soilly AL, Ferdynus C, Desplanches O, Grimaldi M, et al.
        • Paediatric intensive care admissions for respiratory syncytial virus bronchiolitis in France: results of a retrospective survey and evaluation of the validity of a medical information system programme.
      3. Spaeder MC, Fackler JC.
        • A multi-tiered time-series modelling approach to forecasting respiratory syncytial virus incidence at the local level.
      4. Higgins RR, Beniprashad M, Chong-King E, Li Y, et al.
        • Recovery of Influenza B Virus with the H273Y Point Mutation in the neuraminidase Active site from a Human Patient.
      5. Bodewes R, Nieuwkoop NJ, Verburgh RJ, Fouchier RA, et al.
        • The use of influenza A viruses expressing reporter genes to assess the frequency of double infections in vitro.
      6. Li M, Brenwald N, Bonigal S, Chana K, et al.
        • Rapid Diagnosis Of Influenza: An Evaluation Of Two Commercially Available Rt-Pcr Assays.
      7. Mamelund SE.
      8. Widmer K, Zhu Y, Williams JV, Griffin MR, et al.
        • Rates of Hospitalizations for Respiratory Syncytial Virus, Human Metapneumovirus, and Influenza Virus in Older Adults.
      9. Josset L, Belser JA, Pantin-Jackwood MJ, Chang JH, et al.
        • Implication of inflammatory macrophages, nuclear receptors and interferon regulatory factors in increased virulence of pandemic 2009 H1N1 influenza A virus after host adaptation.
      10. Bouvier NM, Rahmat S, Pica N.
        • Enhanced Mammalian Transmissibility of Seasonal Influenza A/H1N1 Viruses Encoding an Oseltamivir-Resistant Neuraminidase.
      11. Gao Q, Chou YY, Doganay S, Vafabakhsh R, et al.
        • The influenza A virus PB2, PA, NP and M segments play a pivotal role during genome packaging.
      12. Marklund JK, Ye Q, Dong J, Tao YJ, et al.
        • Sequence in the Influenza A Virus Nucleoprotein Required for Viral Polymerase Binding and RNA Synthesis.
      13. Elsner RA, Ernst DN, Baumgarth N.
        • Single and co-expression of CXCR4 and CXCR5 identifies CD4 T helper cells in distinct lymph node niches during influenza infection.
      14. Stockwell MS, Kharbanda EO, Martinez RA, Vargas CY, et al.
        • Effect of a text messaging intervention on influenza vaccination in an urban, low-income pediatric and adolescent population: a randomized controlled trial.
      15. ...
        • Severe Coinfection with Seasonal Influenza A (H3N2) Virus and Staphylococcus aureus - Maryland, February-March 2012.
      16. de Vries E, de Vries RP, Wienholts MJ, Floris CE, et al.
        • Influenza A virus entry into cells lacking sialylated N-glycans.
      17. St Paul M, Mallick AI, Read LR, Villanueva AI, et al.
        • Prophylactic treatment with Toll-like receptor ligands enhances host immunity to avian influenza virus in chickens.
      18. Lu AB, Halim AA, Dendle C, Kotsanas D, et al.
        • Influenza vaccination uptake amongst pregnant women and maternal care providers is suboptimal.
      -
      ------

      Comment


      • #18
        Research Articles Abstracts?May 5 2012 Issue

        [Source: AMEDEO, homepage: (LINK).]

        Research Articles Abstracts?May 5 2012 Issue





        Abstracts List
        1. Inglesby TV.
          • Engineered H5N1: a rare time for restraint in science.
        2. Wang X, Zhang W, Liu F, Zheng M, et al.
          • Intranasal immunization with live attenuated influenza vaccine plus chitosan as an adjuvant protects mice against homologous and heterologous virus challenge.
        3. Knight M, Lim B.
        4. Pasternak B, Svanstrom H, Molgaard-Nielsen D, Krause TG, et al.
          • Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark.
        5. Cohen D.
        6. Cohen D.
        7. Doshi P, Jones M, Jefferson T.
        8. Zhou F, Zhou J, Ma L, Song S, et al.
          • High-yield production of a stable Vero cell-based vaccine candidate against the highly pathogenic avian influenza virus H5N1.
        9. Chen R, Mias GI, Li-Pook-Than J, Jiang L, et al.
          • Personal omics profiling reveals dynamic molecular and medical phenotypes.
        10. Harvala H, Gaunt E, McIntyre C, Roddie H, et al.
          • Epidemiology and clinical characteristics of parainfluenza virus 3 outbreak in a Haemato-oncology unit.
        11. Hadler JL, Baker TN, Papadouka V, France AM, et al.
          • Effectiveness of One Dose of 2009 Influenza A (H1N1) Vaccine at Preventing Hospitalization with Pandemic H1N1 Influenza in Children 7 Months to 9 Years of Age.
        12. Pearce MB, Belser JA, Gustin KM, Pappas C, et al.
          • Seasonal Trivalent Inactivated Influenza Vaccine Protects against 1918 Spanish Influenza Virus in Ferrets.
        13. Szilagyi PG, Adams WG.
          • Text messaging: a new tool for improving preventive services.
        14. Kuehn BM.
        15. Osterholm MT, Kelley NS.
          • H5N1 influenza virus seroepidemiological studies: The facts revisited.
        16. Chou YY, Vafabakhsh R, Doganay S, Gao Q, et al.
          • One influenza virus particle packages eight unique viral RNAs as shown by FISH analysis.
        17. Li X, Miao H, Henn A, Topham DJ, et al.
          • Ki-67 expression reveals strong, transient influenza specific CD4 T cell responses after adult vaccination.
        18. Ortega-Sanchez IR, Molinari NA, Fairbrother G, Szilagyi PG, et al.
          • Indirect, out-of-pocket and medical costs from influenza-related illness in young children.
        19. Gomez Y, Leguen F, Zhang G, O'Connell E, et al.
          • Correlates of 2009 H1N1 influenza vaccination among day care-aged children, Miami-Dade County.
        20. Assi TM, Rookkapan K, Rajgopal J, Sornsrivichai V, et al.
          • How influenza vaccination policy may affect vaccine logistics.
        21. Reperant LA, Kuiken T, Osterhaus AD.
          • Adaptive pathways of zoonotic influenza viruses: From exposure to establishment in humans.
        22. Frew PM, Painter JE, Hixson B, Kulb C, et al.
          • Factors mediating seasonal and influenza A (H1N1) vaccine acceptance among ethnically diverse populations in the urban south.
        23. de Haan A, Haijema BJ, Voorn P, Meijerhof T, et al.
          • Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
        24. Jones BG, Sealy R, Rudraraju R, Traina-Dorge V, et al.
          • Sendai virus-based RSV vaccine protects African green monkeys from RSV infection.
        25. Lima HN, Botosso VF, Oliveira DB, Campos AC, et al.
          • Molecular epidemiology of the SH (small hydrophobic) gene of human respiratory syncytial virus (HRSV), over 2 consecutive years.
        26. Lott J, Johnson J.
          • Promising Practices for School-located Vaccination Clinics--: Part II: Clinic Operations and Program Sustainability.
        27. Lott J, Johnson J.
          • Promising Practices for School-located Vaccination Clinics--Part I: Preparation.
        -
        -------

        Comment


        • #19
          Research Articles Abstracts?May 12 2012 Issue

          [Source: AMEDEO, homepage: (LINK).]

          Research Articles Abstracts?May 12 2012 Issue



          Abstracts List
          1. Inglesby TV.
            • Engineered H5N1: a rare time for restraint in science.
          2. Wang X, Zhang W, Liu F, Zheng M, et al.
            • Intranasal immunization with live attenuated influenza vaccine plus chitosan as an adjuvant protects mice against homologous and heterologous virus challenge.
          3. Knight M, Lim B.
          4. Pasternak B, Svanstrom H, Molgaard-Nielsen D, Krause TG, et al.
            • Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark.
          5. Cohen D.
          6. Cohen D.
          7. Doshi P, Jones M, Jefferson T.
          8. Zhou F, Zhou J, Ma L, Song S, et al.
            • High-yield production of a stable Vero cell-based vaccine candidate against the highly pathogenic avian influenza virus H5N1.
          9. Chen R, Mias GI, Li-Pook-Than J, Jiang L, et al.
            • Personal omics profiling reveals dynamic molecular and medical phenotypes.
          10. Harvala H, Gaunt E, McIntyre C, Roddie H, et al.
            • Epidemiology and clinical characteristics of parainfluenza virus 3 outbreak in a Haemato-oncology unit.
          11. Hadler JL, Baker TN, Papadouka V, France AM, et al.
            • Effectiveness of One Dose of 2009 Influenza A (H1N1) Vaccine at Preventing Hospitalization with Pandemic H1N1 Influenza in Children 7 Months to 9 Years of Age.
          12. Pearce MB, Belser JA, Gustin KM, Pappas C, et al.
            • Seasonal Trivalent Inactivated Influenza Vaccine Protects against 1918 Spanish Influenza Virus in Ferrets.
          13. Szilagyi PG, Adams WG.
            • Text messaging: a new tool for improving preventive services.
          14. Kuehn BM.
          15. Osterholm MT, Kelley NS.
            • H5N1 influenza virus seroepidemiological studies: The facts revisited.
          16. Chou YY, Vafabakhsh R, Doganay S, Gao Q, et al.
            • One influenza virus particle packages eight unique viral RNAs as shown by FISH analysis.
          17. Li X, Miao H, Henn A, Topham DJ, et al.
            • Ki-67 expression reveals strong, transient influenza specific CD4 T cell responses after adult vaccination.
          18. Ortega-Sanchez IR, Molinari NA, Fairbrother G, Szilagyi PG, et al.
            • Indirect, out-of-pocket and medical costs from influenza-related illness in young children.
          19. Gomez Y, Leguen F, Zhang G, O'Connell E, et al.
            • Correlates of 2009 H1N1 influenza vaccination among day care-aged children, Miami-Dade County.
          20. Assi TM, Rookkapan K, Rajgopal J, Sornsrivichai V, et al.
            • How influenza vaccination policy may affect vaccine logistics.
          21. Reperant LA, Kuiken T, Osterhaus AD.
            • Adaptive pathways of zoonotic influenza viruses: From exposure to establishment in humans.
          22. Frew PM, Painter JE, Hixson B, Kulb C, et al.
            • Factors mediating seasonal and influenza A (H1N1) vaccine acceptance among ethnically diverse populations in the urban south.
          23. de Haan A, Haijema BJ, Voorn P, Meijerhof T, et al.
            • Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
          24. Jones BG, Sealy R, Rudraraju R, Traina-Dorge V, et al.
            • Sendai virus-based RSV vaccine protects African green monkeys from RSV infection.
          25. Lima HN, Botosso VF, Oliveira DB, Campos AC, et al.
            • Molecular epidemiology of the SH (small hydrophobic) gene of human respiratory syncytial virus (HRSV), over 2 consecutive years.
          26. Lott J, Johnson J.
            • Promising Practices for School-located Vaccination Clinics--: Part II: Clinic Operations and Program Sustainability.
          27. Lott J, Johnson J.
            • Promising Practices for School-located Vaccination Clinics--Part I: Preparation.
          -
          -------

          Comment


          • #20
            Research Articles Abstracts?May 19 2012 Issue

            [Source: AMEDEO, homepage: (LINK).]
            Research Articles Abstracts?May 19 2012 Issue



            Abstracts List
            1. VAN BORM S, Rosseel T, Vangeluwe D, Vandenbussche F, et al.
            2. BIDOKHTI MR, Traven M, Ohlson A, Zarnegar B, et al.
            3. PONNAMBALAM L, Samavedham L, Lee HR, Ho CS, et al.
            4. LEUNG YH, Lim WL, Wong MH, Chuang SK, et al.
            5. PING J, Selman M, Tyler S, Forbes N, et al.
            6. HELDT FS, Frensing T, Reichl U.
            7. SHAW A.
            8. TOH MP, Kannan P, Chen Y, Chng FL, et al.
            9. XU J, Huang D, Liu S, Lin H, et al.
            10. CAMPITELLI MA, Inoue M, Calzavara AJ, Kwong JC, et al.
              1. Low Rates of Influenza Immunization in Young Children Under Ontario's Universal Influenza Immunization Program.
                1. Pediatrics. 2012.
                2. PubMed: www.amedeo.com/p2.php?id=22585770&s=flu&pm=2
                3. ABSTRACT available
                4. Share: http://hub.amedeo.com/22585770

            We have screened the following journals for you:
            • Am J Med
            • Ann Intern Med
            • Antimicrob Agents Chemother
            • Antiviral Res
            • Arch Intern Med
            • Arch Virol
            • Biochem Biophys Res Commun
            • Biochem Soc Trans
            • Biochemistry
            • BMJ
            • Cell
            • Clin Diagn Lab Immunol
            • Commun Dis Rep CDR Wkly
            • Drug Saf
            • Drugs
            • Epidemiol Infect
            • Eur J Epidemiol
            • J Clin Microbiol
            • J Epidemiol Community Health
            • J Exp Med
            • J Gen Virol
            • J Immunol
            • J Infect
            • J Infect Dis
            • J Virol
            • J Virol Methods
            • JAMA
            • Lancet
            • MMWR Morb Mortal Wkly Rep
            • N Engl J Med
            • Pediatrics
            • Proc Natl Acad Sci U S A
            • Vaccine
            • Virology
            • Virus Res

            -
            -------

            Comment


            • #21
              Research Articles Abstracts ? May 26 2012 Issue

              [Source: AMEDEO, homepage: (LINK).]

              Research Articles Abstracts ? May 26 2012 Issue



              Abstracts List
              1. Simeonova L, Gegova G, Galabov AS.
                • Prophylactic and therapeutic combination effects of rimantadine and oseltamivir against influenza virus a (H3N2) infection in mice.
              2. Starick E, Lange E, Grund C, Grosse Beilage E, et al.
                • Reassortants of pandemic influenza A virus H1N1/2009 and endemic porcine HxN2 viruses emerge in swine populations in Germany.
              3. Flynn PM, Nachman S, Muresan P, Fenton T, et al.
                • Safety and Immunogenicity of 2009 Pandemic H1N1 Influenza Vaccination in Perinatally HIV-1 Infected Children and Youth.
              4. Miller AL, Sims GP, Brewah YA, Rebelatto MC, et al.
                • Opposing roles of membrane and soluble forms of the receptor for advanced glycation end products in primary respiratory syncytial virus infection.
              5. Roelandt S, Outtrim L, Browning C, Alexander DJ, et al.
                • Evaluation of two different swab transport systems in the detection of avian influenza virus excretion from infected Pekin ducks (Anas platyrhynchos).
              6. Noda T, Kawaoka Y.
                • Packaging of influenza virus genome: Robustness of selection.
              7. Li GM, Chiu C, Wrammert J, McCausland M, et al.
                • Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells.
              8. Roy A, Post CB.
                • Long-distance correlations of rhinovirus capsid dynamics contribute to uncoating and antiviral activity.
              9. Villenave R, Thavagnanam S, Sarlang S, Parker J, et al.
                • In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo.
              10. Hatz C, Cramer JP, Vertruyen A, Schwarz TF, et al.
                • A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations.
              11. Graitcer SB, Dube NL, Basurto-Davila R, Smith PF, et al.
                • Effects of immunizing school children with 2009 influenza A (H1N1) monovalent vaccine on absenteeism among students and teachers in Maine.
              12. Domingues CM, de Oliveira WK.
                • Uptake of pandemic influenza (H1N1)-2009 vaccines in Brazil, 2010.
              13. Ebrahimi SM, Dabaghian M, Tebianian M, Zabeh Jazi MH, et al.
                • In contrast to conventional inactivated influenza vaccines, 4xM2e.HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A isolates circulating in Iran.
              14. Jazi MH, Dabaghian M, Tebianian M, Gharagozlou MJ, et al.
                • In vivo electroporation enhances immunogenicity and protection against influenza A virus challenge of an M2e-HSP70c DNA vaccine.
              15. Pantin-Jackwood MJ, Smith DM, Wasilenko JL, Cagle C, et al.
                • Effect of age on the pathogenesis and innate immune responses in Pekin ducks infected with different H5N1 highly pathogenic avian influenza viruses.
              16. Katsumi Y, Otabe O, Matsui F, Kidowaki S, et al.
                • Effect of a Single Inhalation of Laninamivir Octanoate in Children With Influenza.
              -
              ------

              Comment


              • #22
                Research Articles Abstracts?June 2 2012 Issue

                [Source: AMEDEO, homepage: (LINK).]

                Research Articles Abstracts?June 2 2012 Issue



                Abstracts List
                1. Xie T, Liang J, Liu N, Wang Q, et al.
                  • MicroRNA-127 inhibits lung inflammation by targeting IgG Fcgamma receptor I.
                2. Terrier O, Marcel V, Cartet G, Lane DP, et al.
                  • Influenza A viruses control the expression of pro-viral human p53 isoforms, p53beta and {Delta}133p53alpha
                3. Bodewes R, Fraaij PL, Kreijtz JH, Geelhoed-Mieras MM, et al.
                  • Annual influenza vaccination affects the development of heterosubtypic immunity.
                4. Prematunge C, Corace K, McCarthy A, Nair R, et al.
                  • Factors influencing pandemic influenza vaccination of healthcare workers-A systematic review.
                5. Zhang J, While AE, Norman IJ.
                  • Nurses' vaccination against pandemic H1N1 influenza and their knowledge and other factors.
                6. Creskey MC, Li C, Wang J, Girard M, et al.
                  • Simultaneous quantification of the viral antigens hemagglutinin and neuraminidase in influenza vaccines by LC-MS(E).
                7. Middleman AB, Short MB, Doak JS.
                  • School-located influenza immunization programs: Factors important to parents and students.
                8. Wells G, Addington-Hall M, Malur AG.
                  • Mutations within the human parainfluenza virus type 3C protein affect viral replication and host interferon induction.
                -
                -------

                Comment


                • #23
                  Research Articles Abstracts ? June 8 2012 Issue

                  [Source: AMEDEO, homepage: (LINK).]

                  Research Articles Abstracts ? June 8 2012 Issue



                  Abstracts List
                  1. CHIAPPONI C, Moreno A, Barbieri I, Merenda M, et al.
                  2. ARVIA R, Corcioli F, Simi L, Orlando C, et al.
                  3. YU M, Li G, Lee WW, Yuan M, et al.
                  4. PETOUSIS-HARRIS H, Poole T, Turner N, Reynolds G, et al.
                  5. RIVERA L, Mazara S, Vargas M, Fragapane E, et al.
                  6. CHANG YT, Guo CY, Tsai MS, Cheng YY, et al.
                  7. SCHEIFELE DW, Ward BJ, Dionne M, Vanderkooi OG, et al.
                  8. HUTCHINSON EC, Fodor E.
                  9. SWAYNE DE, Eggert D, Beck JR.
                  10. QUAN FS, Kim MC, Lee BJ, Song JM, et al.
                  11. ABED Y, Pizzorno A, Boivin G.
                  -
                  ------

                  Comment


                  • #24
                    Research Articles Abstracts ? June 16 2012 Issue

                    [Source: AMEDEO, homepage: (LINK).]

                    Research Articles Abstracts ? June 16 2012 Issue



                    Abstracts List
                    1. Pebody RG, Andrews N, Fleming DM, McMenamin J, et al.
                      • Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom.
                    2. Henning J, Morton JM, Wibawa H, Yulianto D, et al.
                      • Incidence and risk factors for H5 highly pathogenic avian influenza infection in flocks of apparently clinically healthy ducks.
                    3. Sayers G, Igoe D, Carr M, Cosgrave M, et al.
                      • High morbidity and mortality associated with an outbreak of influenza A(H3N2) in a psycho-geriatric facility.
                    4. Redlberger-Fritz M, Aberle JH, Popow-Kraupp T, Kundi M, et al.
                      • Attributable deaths due to influenza: a comparative study of seasonal and pandemic influenza.
                    5. Tacon CE, Newton R, Proud D, Leigh R, et al.
                      • Rhinovirus-induced MMP-9 expression is dependent on Fra-1, which is modulated by formoterol and dexamethasone.
                    6. Newcomb DC, Boswell MG, Huckabee MM, Goleniewska K, et al.
                      • IL-13 regulates Th17 secretion of IL-17A in an IL-10-dependent manner.
                    7. Zhou J, To KK, Dong H, Cheng ZS, et al.
                      • A functional variation in CD55 gene increases the disease severity of pandemic A(H1N1)2009 influenza infection.
                    8. Moisy D, Avilov SV, Jacob Y, Laoide BM, et al.
                      • HMGB1 protein binds to influenza virus nucleoprotein and promotes viral replication.
                    9. Nelson MI, Vincent AL, Kitikoon P, Holmes EC, et al.
                      • The evolution of novel reassortant A/H3N2 influenza viruses in North American swine and humans, 2009-2011.
                    10. Weeks-Gorospe JN, Hurtig HR, Iverson AR, Schuneman MJ, et al.
                      • Naturally occurring swine influenza A virus PB1-F2 phenotypes that contribute to super-infection with Gram-positive respiratory pathogens.
                    11. Varga ZT, Grant A, Manicassamy B, Palese P, et al.
                      • The Influenza Virus Protein PB1-F2 Inhibits the Induction of Type I Interferon by Binding to MAVS and Decreasing the Mitochondrial Membrane Potential.
                    12. Yang H, Carney PJ, Donis RO, Stevens J, et al.
                      • Structure and receptor complexes of the hemagglutinin from a highly pathogenic H7N7 influenza virus.
                    13. O'Donnell CD, Wright A, Vogel L, Wei CJ, et al.
                      • The effect of priming with H1N1 influenza viruses of variable antigenic distance on challenge with 2009 pandemic H1N1 virus.
                    14. Enquist LW.
                      • Select agent publications and the H5N1 influenza virus controversy: a Journal of Virology Perspective.
                    15. Schrauwen EJ, Herfst S, Leijten LM, van Run P, et al.
                      • The multibasic cleavage site in H5N1 virus is critical for systemic spread along the olfactory and hematogenous routes in ferrets.
                    16. Harrison MS, Schmitt PT, Pei Z, Schmitt AP, et al.
                      • Role of ubiquitin in parainfluenza virus 5 particle formation.
                    17. Jian-Umpunkul P, Thepthai C, Apiwat N, Chantima W, et al.
                      • Improved sensitivity of Influenza A antigen detection using a combined NP, M, and NS1 sandwich ELISA.
                    18. ...
                      • Update: influenza activity - United States, 2011-12 season and composition of the 2012-13 influenza vaccine.
                    19. Luytjes W, Enouf V, Schipper M, Gijzen K, et al.
                      • HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains.
                    20. Wilks S, de Graaf M, Smith DJ, Burke DF, et al.
                      • A review of influenza haemagglutinin receptor binding as it relates to pandemic properties.
                    -
                    -------

                    Comment


                    • #25
                      Research Articles Abstracts?June 23 2012 Issue

                      [Source: AMEDEO, homepage: (LINK).]

                      Research Articles Abstracts?June 23 2012 Issue



                      Abstracts List
                      1. Kmietowicz Z.
                        • Research on potential of bird flu virus to spread between humans is finally published.
                      2. Tsui HY, Lau JT, Lin C, Choi KC, et al.
                        • Prevalence of seasonal influenza vaccination and associated factors in people with chronic diseases in Hong Kong.
                      3. Croville G, Soubies SM, Barbieri J, Klopp C, et al.
                        • Field Monitoring of Avian Influenza Viruses: Whole Genome Sequencing and Tracking of Neuraminidase Evolution Using 454 Pyrosequencing.
                      4. Nivin B, Zancocchio T.
                        • Cluster of False-Positive Influenza B Rapid Antigen Tests in a New York City Hospital.
                      5. Westgeest KB, de Graaf M, Fourment M, Bestebroer TM, et al.
                        • Genetic Evolution of Neuraminidase of Influenza A (H3N2) Viruses from 1968 to 2009 and its Correspondence to Hemagglutinin.
                      6. Mgbemena V, Segovia JA, Chang TH, Tsai SY, et al.
                        • Transactivation of Inducible Nitric Oxide Synthase Gene by Kruppel-like Factor 6 Regulates Apoptosis during Influenza A Virus Infection.
                      7. Xu R, Zhu X, McBride R, Nycholat CM, et al.
                        • Functional Balance of the Hemagglutinin and Neuraminidase Activities Accompanies the Emergence of the 2009 H1N1 Influenza Pandemic.
                      8. Qi L, Davis AS, Jagger BW, Schwartzman LM, et al.
                        • Analysis by single gene reassortment demonstrates that the 1918 influenza virus is functionally compatible with a low pathogenicity avian influenza virus in mice.
                      9. Nelli RK, Dunham SP, Kuchipudi SV, White GA, et al.
                        • Mammalian Innate Resistance to Highly Pathogenic Avian Influenza H5N1 Virus Infection is Mediated through Reduced Pro-inflammation and Infectious Virus Release.
                      10. Babon JA, Cruz J, Ennis FA, Yin L, et al.
                        • A human CD4+ T cell epitope in the influenza hemagglutinin is cross-reactive to influenza A subtypes and to influenza B virus.
                      11. Brock LG, Karron RA, Krempl CD, Collins PL, et al.
                        • Evaluation of pneumonia virus of mice as a possible human pathogen.
                      12. Ioannidis I, McNally B, Willette M, Peeples ME, et al.
                        • Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection.
                      13. Verma N, Dimitrova M, Carter DM, Crevar CJ, et al.
                        • Influenza virus H1N1pdm09 infections in the young and old: evidence of greater antibody diversity and affinity for the hemagglutinin globular head domain (HA1 Domain) in the elderly than in young adults and children.
                      14. Zeng R, Zhang H, Hai Y, Cui Y, et al.
                        • IL-27 inhibits vaccine-enhanced pulmonary disease following respiratory syncytial virus infection by regulating cellular memory responses.
                      15. Gordon DL, Sajkov D, Woodman RJ, Honda-Okubo Y, et al.
                        • Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax polysaccharide adjuvant.
                      16. Sullender W, Fowler K, Krishnan A, Gupta V, et al.
                        • Design and initiation of a study to assess the direct and indirect effects of influenza vaccine given to children in rural India.
                      17. Isken B, Genzel Y, Reichl U.
                        • Productivity, apoptosis, and infection dynamics of influenza A/PR/8 strains and A/PR/8-based reassortants.
                      18. Xu K, Ferreri L, Rimondi A, Olivera V, et al.
                        • Isolation and characterization of an H9N2 influenza virus isolated in Argentina.
                      19. Bulkow LR, Singleton RJ, DeByle C, Miernyk K, et al.
                        • Risk factors for hospitalization with lower respiratory tract infections in children in rural Alaska.
                      -
                      -------

                      Comment


                      • #26
                        Research Articles Abstracts?June 30 2012 Issue

                        [Source: AMEDEO, homepage: (LINK).]

                        Research Articles Abstracts?June 30 2012 Issue



                        Abstracts List
                        1. Yong E.
                        2. Sun Z, Huber V, McCormick K, Kaushik RS, et al.
                          • Characterization of a porcine intestinal epithelial cell line for influenza virus production.
                        3. van Asten L, van den Wijngaard C, van Pelt W, van de Kassteele J, et al.
                          • MORTALITY ATTRIBUTABLE TO 9 COMMON INFECTIONS: significant effect of influenza A, RSV, influenza B, norovirus and parainfluenza in the elderly.
                        4. Inagaki A, Goto H, Kakugawa S, Ozawa M, et al.
                          • Competitive incorporation of homologous gene segments of influenza A virus into virions.
                        5. Vanderlinden E, Vanstreels E, Boons E, Ter Veer W, et al.
                          • Intracytoplasmic trapping of influenza virus by a lipophilic derivative of aglycoristocetin.
                        6. Zhang Y, Zhang Q, Gao Y, He X, et al.
                          • Key molecular factors in HA and PB2 contribute to the efficient transmission of the 2009 H1N1 pandemic influenza virus.
                        7. Jiao P, Wei L, Yuan R, Song Y, et al.
                          • Complete Genome Sequence of an H7N3 Avian Influenza Virus Isolated from Ducks in Southern China.
                        8. Jiao P, Yuan R, Song Y, Wei L, et al.
                          • Full Genome Sequence of a Recombinant H5N1 Influenza Virus from a Condor in Southern China.
                        9. Jiao P, Yuan R, Wei L, Jia B, et al.
                          • Complete Genomic Sequence of a Novel Natural Recombinant H6N2 Influenza Virus from Chickens in Guangdong, Southern China.
                        10. Jiao P, Cao L, Yuan R, Wei L, et al.
                          • Complete Genome Sequence of an H10N8 Avian Influenza Virus Isolated from a Live Bird Market in Southern China.
                        11. Lombardo T, Dotti S, Renzi S, Ferrari M, et al.
                          • Susceptibility of different cell lines to Avian and Swine Influenza viruses.
                        12. Sancho A, Melchiorri D, Abadie E.
                        13. Catlin EA, Warren HS, Shailam R, Lahoud-Rahme M, et al.
                          • Case records of the Massachusetts General Hospital. Case 19-2012. A premature newborn boy with respiratory distress.
                        14. Honda-Okubo Y, Saade F, Petrovsky N.
                          • Advax, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses.
                        15. Li S, Zhu J.
                          • Are the atypical forms of Guillain-Barre syndrome correlated with H1N1-influenza vaccination?
                        16. De Vleeschauwer AR, Baras B, Kyriakis CS, Jacob V, et al.
                          • Efficacy of an AS03(A)-adjuvanted split H5N1 influenza vaccine against an antigenically distinct low pathogenic H5N1 virus in pigs.
                        17. Huang WT, Huang WI, Huang YW, Hsu CW, et al.
                          • The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: A capture-recapture analysis.
                        18. Weston WM, Friedland LR, Wu X, Howe B, et al.
                          • Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix((R))): Results of two randomized trials.
                        19. Tandale BV, Pawar SD, Mishra AC.
                          • Immunogenicity and safety of pandemic H1N1 2009 vaccine among adults in field use, India.
                        20. Easterbrook JD, Schwartzman LM, Gao J, Kash JC, et al.
                          • Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice.
                        -
                        ------

                        Comment


                        • #27
                          Research Articles Abstract?July 7 2012 Issue

                          [Source: AMEDEO, homepage: (LINK).]

                          Research Articles Abstract?July 7 2012 Issue



                          Abstract List
                          1. Fisman DN.
                            • Getting schooled: school closure, age distribution, and pandemic mitigation.
                          2. Arafa A, Suarez D, Kholosy SG, Hassan MK, et al.
                            • Evolution of highly pathogenic avian influenza H5N1 viruses in Egypt indicating progressive adaptation.
                          3. Hai-Bo W, Ru-Feng L, En-Kang W, Jin-Biao Y, et al.
                            • Sequence and phylogenetic analysis of H7N3 avian influenza viruses isolated from poultry in China in 2011.
                          4. Giles BM, Crevar CJ, Carter DM, Bissel SJ, et al.
                            • A Computationally-Optimized Hemagglutinin VLP Vaccine Elicits Broadly-Reactive Antibodies that Protect Non-Human Primates from H5N1 Infection.
                          5. Tarbet EB, Dorward JT, Day CW, Rashid KA, et al.
                            • Vaccine production training to develop the workforce of foreign institutions supported by the BARDA influenza vaccine capacity building program.
                          6. Bliu A, Lemieux M, Li C, Li X, et al.
                            • Modifying the thermostability of inactivated influenza vaccines.
                          7. Eppes C, Wu A, Cameron KA, Garcia P, et al.
                            • Does obstetrician knowledge regarding influenza increase HINI vaccine acceptance among their pregnant patients?
                          8. Cheng X, Zengel JR, Xu Q, Jin H, et al.
                            • Surface glycoproteins of influenza A H3N2 virus modulate virus replication in the respiratory tract of ferrets.
                          -
                          ------

                          Comment


                          • #28
                            Research Articles Abstracts?July 14 2012 Issue

                            [Source: AMEDEO, homepage: (LINK).]

                            Research Articles Abstracts?July 14 2012 Issue



                            Abstracts List
                            1. SCHUCHAT A, Katz JM.
                            2. JACKSON LA, Chen WH, Stapleton JT, Dekker CL, et al.
                            3. HSIANG TY, Zhou L, Krug RM.
                            4. LIN L, Liu Q, Berube N, Detmer S, et al.
                            5. KRAMMER F, Pica N, Hai R, Tan GS, et al.
                            6. RUCKLE A, Haasbach E, Julkunen I, Planz O, et al.
                            7. STEINHOFF MC, MacDonald NE.
                            8. DE WALS P, Deceuninck G, Toth E, Boulianne N, et al.
                            9. PASTERNAK B, Svanstrom H, Molgaard-Nielsen D, Krause TG, et al.
                            10. LANGLOIS RA, Varble A, Chua MA, Garcia-Sastre A, et al.
                            11. COHEN S, Janicki-Deverts D, Doyle WJ, Miller GE, et al.
                            12. BLONDEL B, Mahjoub N, Drewniak N, Launay O, et al.
                            13. CANDELA S, Pergolizzi S, Ragni P, Cavuto S, et al.
                            14. WANITCHANG A, Narkpuk J, Jaru-Ampornpan P, Jengarn J, et al.
                            15. TERRIER O, Moules V, Carron C, Cartet G, et al.
                            We have screened the following journals for you:
                            • Am J Med
                            • Ann Intern Med
                            • Antimicrob Agents Chemother
                            • Antiviral Res
                            • Arch Intern Med
                            • Arch Virol
                            • Biochem Biophys Res Commun
                            • Biochem Soc Trans
                            • Biochemistry
                            • BMJ
                            • Cell
                            • Clin Diagn Lab Immunol
                            • Commun Dis Rep CDR Wkly
                            • Drug Saf
                            • Drugs
                            • Epidemiol Infect
                            • Eur J Epidemiol
                            • J Clin Microbiol
                            • J Epidemiol Community Health
                            • J Exp Med
                            • J Gen Virol
                            • J Immunol
                            • J Infect
                            • J Infect Dis
                            • J Virol
                            • J Virol Methods
                            • JAMA
                            • Lancet
                            • MMWR Morb Mortal Wkly Rep
                            • N Engl J Med
                            • Pediatrics
                            • Proc Natl Acad Sci U S A
                            • Vaccine
                            • Virology
                            • Virus Res
                            -
                            -------

                            Comment


                            • #29
                              Research Articles Abstracts?July 21 2012 Issue

                              [Source: AMEDEO, homepage: (LINK).]

                              Research Articles Abstracts?July 21 2012 Issue



                              Abstracts List
                              1. Kheiri MT, Jamali A, Shenagari M, Hashemi H, et al.
                                • Influenza virosome/DNA vaccine complex as a new formulation to induce intra-subtypic protection against influenza virus challenge.
                              2. Smee DF, Julander JG, Bart Tarbet E, Gross M, et al.
                                • Treatment of Oseltamivir-Resistant Influenza A (H1N1) Virus Infections in Mice With Antiviral Agents.
                              3. Mon PP, Lapkuntod J, Maw MT, Nuansrichay B, et al.
                                • Highly pathogenic avian influenza (H5N1) in Myanmar, 2006-2010.
                              4. Lugner AK, van Boven M, de Vries R, Postma MJ, et al.
                                • Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis.
                              5. Plosker GL.
                                • A/H5N1 Prepandemic Influenza Vaccine (Whole Virion, Vero Cell-Derived, Inactivated) [Vepacel(R)].
                              6. Benoit SR, Burkom H, McIntyre AF, Kniss K, et al.
                                • Pneumonia in US hospitalized patients with influenza-like illness: BioSense, 2007-2010.
                              7. Freitas FT, Cabral AP, Barros EN, Burigo MJ, et al.
                                • Pre-symptomatic transmission of pandemic influenza H1N1 2009: investigation of a family cluster, Brazil.
                              8. Arnold ME, Irvine RM, Tearne O, Rae D, et al.
                                • Investigation into sampling strategies in response to potential outbreaks of low pathogenicity notifiable avian influenza initiated in commercial duck holdings in Great Britain.
                              9. Gubbels S, Krause TG, Bragstad K, Perner A, et al.
                                • Burden and characteristics of influenza A and B in Danish intensive care units during the 2009/10 and 2010/11 influenza seasons.
                              10. Watanabe Y, Ibrahim MS, Ellakany HF, Kawashita N, et al.
                                • Antigenic Analysis of Highly Pathogenic Avian Influenza Virus H5N1 Sublineages Co-Circulating in Egypt.
                              11. Nelson M, Gramer M, Vincent A, Holmes EC, et al.
                                • Global transmission of influenza viruses from humans to swine.
                              12. Frey SE, Bernstein DI, Gerber MA, Keyserling HL, et al.
                                • Safety and Immune Responses in Children after Concurrent or Sequential 2009 H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations.
                              13. Lichenstein R, Magder LS, King RE, King JC Jr, et al.
                                • The relationship between influenza outbreaks and acute ischemic heart disease in Maryland residents over a seven-year period.
                              14. Vincent AL, Ma W, Lager KM, Richt JA, et al.
                                • Live attenuated influenza vaccine provides superior protection from heterologous infection in pigs with maternal antibodies without inducing vaccine associated enhanced respiratory disease.
                              15. Hamilton BS, Gludish DW, Whittaker GR.
                                • Cleavage Activation of the Human-Adapted Influenza Virus Subtypes by Matriptase Reveals Both Subtype- and Strain-Specificity.
                              16. Wong DD, Choy KT, Chan RW, Sia SF, et al.
                                • Comparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation.
                              17. Miyoshi-Akiyama T, Akasaka Y, Oogane T, Kondo Y, et al.
                                • Development and Evaluation of a Line Probe Assay for Rapid Typing of Influenza Viruses and Detection of the H274Y Mutation.
                              18. de-Paris F, Beck C, Machado AB, Paiva RM, et al.
                                • Optimization of one-step duplex real-time rt-pcr for detection of influenza and respiratory syncytial virus in nasopharyngeal aspirates.
                              19. Lung O, Beeston A, Ohene-Adjei S, Pasick J, et al.
                                • Electronic microarray assays for avian influenza and Newcastle disease virus.
                              20. Houspie L, Keyaerts E, Maes P, Van Ranst M, et al.
                                • Susceptibility of the PER.C6 cell line for infection with clinical human respiratory syncytial virus isolates.
                              21. Taylor DN, Treanor JJ, Sheldon EA, Johnson C, et al.
                                • Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response.
                              22. Dominguez A, Castilla J, Godoy P, Delgado-Rodriguez M, et al.
                                • Effectiveness of pandemic and seasonal influenza vaccines in preventing pandemic influenza-associated hospitalization.
                              23. Boonnak K, Paskel M, Matsuoka Y, Vogel L, et al.
                                • Evaluation of replication, immunogenicity and protective efficacy of a live attenuated cold-adapted pandemic H1N1 influenza virus vaccine in non-human primates.
                              24. Newall AT, Dehollain JP, Wood JG.
                                • Under-explored assumptions in influenza vaccination models: Implications for the universal vaccination of children.
                              25. Maltezou HC, Kallogeropoulou C, Pergialiotis V, Siahanidou T, et al.
                                • Acceptance of a post-partum influenza vaccination (cocooning) strategy for neonates in Greece.
                              26. **** IF, Levin Y, To KK.
                                • Quantitative and qualitative analysis of antibody response after dose sparing intradermal 2009 H1N1 vaccination.
                              27. Ducatez MF, Ilyushina NA, Fabrizio TP, Rehg JE, et al.
                                • Both influenza hemagglutinin and polymerase acidic genes are important for delayed pandemic 2009 H1N1 virus clearance in the ferret model.
                              -
                              -------

                              Comment


                              • #30
                                Research Articles Abstracts?July 28 2012 Issue

                                [Source: AMEDEO, homepage: (LINK).]

                                Research Articles Abstracts?July 28 2012 Issue



                                Abstracts List
                                1. St Louis C, Zorlu G.
                                2. Kmietowicz Z.
                                  • Lack of warnings over flu may have led to more deaths in year after pandemic, say experts.
                                3. Huang P, Liang LJ, Hou NM, Zhang X, et al.
                                  • Phylogenetic, molecular and drug-sensitivity analysis of HA and NA genes of human H3N2 influenza A viruses in Guangdong, China, 2007-2011.
                                4. Rajatonirina S, Rakotosolofo B, Rakotomanana F, Randrianasolo L, et al.
                                  • Excess mortality associated with the 2009 A(H1N1)v influenza pandemic in Antananarivo, Madagascar.
                                5. Pena L, Vincent AL, Loving CL, Henningson JN, et al.
                                  • Strain-dependent Effects of PB1-F2 of Triple Reassortant H3N2 Influenza Viruses in Swine.
                                6. Gutierrez-Pizarraya A, Perez-Romero P, Alvarez R, Aydillo TA, et al.
                                  • Unexpected severity of cases of influenza B infection in patients that required hospitalization during the first postpandemic wave.
                                7. Loeb M, Singh PK, Fox J, Russell ML, et al.
                                  • Longitudinal Study of Influenza Molecular Viral Shedding in Hutterite Communities.
                                8. Niemann S, Ehrhardt C, Medina E, Warnking K, et al.
                                  • The Combined Action of Influenza Virus and Staphylococcus aureus Panton-Valentine Leukocidin Provokes Severe Lung Epithelium Damage.
                                9. Azziz Baumgartner E, Dao C, Nasreen S, Bhuiyan MU, et al.
                                  • Seasonality, timing, and climate drivers of influenza activity worldwide.
                                10. Weinheimer VK, Becher A, Tonnies M, Holland G, et al.
                                  • Influenza A viruses target type II pneumocytes in the human lung.
                                11. Cheung CY, Chan EY, Krasnoselsky A, Purdy D, et al.
                                  • H5N1 Virus Causes Significant Perturbations in Host Proteome Very Early in Influenza Virus-Infected Primary Human Monocyte-Derived Macrophages.
                                12. Malur M, Gale M Jr, Krug RM.
                                  • LGP2 Downregulates Interferon Production During Infection By Seasonal Human Influenza A Viruses That Activate IRF3.
                                13. Leung HS, Li OT, Chan RW, Chan MC, et al.
                                  • The virus entry of influenza A virus with a alpha2,6-linked sialic acid binding preference requires host fibronectin.
                                14. Jeisy-Scott V, Kim JH, Davis WG, Cao W, et al.
                                  • TLR7 recognition is dispensable for influenza virus A infection, but important for the induction of hemagglutinin-specific antibodies in response to the 2009 pandemic split vaccine in mice.
                                15. ...
                                  • Notes from the Field: Outbreak of Influenza A (H3N2) Virus Among Persons and Swine at a County Fair - Indiana, July 2012.
                                16. Loving CL, Vincent AL, Pena L, Perez DR, et al.
                                  • Heightened adaptive immune responses following vaccination with a temperature-sensitive, live-attenuated influenza virus compared to adjuvanted, whole-inactivated virus in pigs.
                                17. van Riet E, Ainai A, Suzuki T, Hasegawa H, et al.
                                  • Mucosal IgA responses in influenza virus infections; thoughts for vaccine design.
                                18. Nowalk MP, Nutini J, Raymund M, Ahmed F, et al.
                                  • Evaluation of a toolkit to introduce standing orders for influenza and pneumococcal vaccination in adults: A multimodal pilot project.
                                19. Hunt C, Arthur A.
                                  • Student nurses' reasons behind the decision to receive or decline influenza vaccine: A cross-sectional survey.
                                20. Ortqvist A, Bennet R, Rinder MR, Lindblad H, et al.
                                  • Effectiveness of the monovalent AS03-adjuvanted influenza A(H1N1)pdm09 vaccine against hospitalization in children because of influenza.
                                21. Puig-Barbera J, Diez-Domingo J, Arnedo-Pena A, Ruiz-Garcia M, et al.
                                  • Effectiveness of the 2010-2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: A case-case comparison, case-control study.
                                22. MacIntyre CR, Ridda I, Seale H, Gao Z, et al.
                                  • Respiratory viruses transmission from children to adults within a household.
                                23. Nguyen T, Rivailler P, Davis CT, Thi Hoa D, et al.
                                  • Evolution of highly pathogenic avian influenza (H5N1) virus populations in Vietnam between 2007 and 2010.
                                24. Scagnolari C, Midulla F, Riva E, Monteleone K, et al.
                                  • Evaluation of interleukin 28B single nucleotide polymorphisms in infants suffering from bronchiolitis.
                                -
                                -------

                                Comment

                                Working...
                                X